BridgeBio Pharma Announces Phase 2 Results From Acoramidis Study
BridgeBio Pharma (NASDQ:BBIO), a commercial-stage biopharmaceutical company developing medicines for patients suffering from genetic diseases and cancers with clear genetic drivers, recently reported updated results from its ongoing Phase 2 study for acoramidis. The study ... [Read]
Renren Inc. Announces Software License Agreement
PR Newswire PHOENIX , April 8, 2022 /PRNewswire/ — Renren Inc. (NYSE: RENN) (” Renren ” or the ” Company “), announces today that the Company, has signed a Software License and Distribution Agreement (” License ... [Read]
CloudMD Announces CEO Succession
Dr. Essam Hamza stepping down as CEO and President, Karen Adams appointed as Interim CEO VANCOUVER, British Columbia, April 06, 2022 — CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF) (“CloudMD” or the “Company”), a healthcare technology ... [Read]
The INX Digital Company Corporate Quarterly Update
NEW YORK and TORONTO, April 1, 2022 — The INX Digital Company, Inc. (NEO:INXD) (the “Company“), the owner of digital asset trading platforms, is pleased to share our Corporate Quarterly Update. March has been a busy month for The ... [Read]